Bioptik Technology Incorporation (4161.TWO)
TWD 31.6
(-2.17%)
TWD 31.6
(-2.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 205.95 Million | 55.05 Million | -41.15 Million | 6.57 Million | - |
| Net Income | 106.47 Million | 62.8 Million | 19.61 Million | -63.69 Million | - |
| Depreciation & Amortization | 34.71 Million | 33.47 Million | 36.98 Million | 37.75 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 5.4 Million | - | - | - | - |
| Change in working capital | 82.93 Million | -45.63 Million | -103.21 Million | 26.28 Million | - |
| Other non-cash items | 282 Thousand | 5.21 Million | 6.52 Million | 10.16 Million | - |
| Investing Cash Flow | -28.53 Million | 187.14 Million | -118.61 Million | -132.83 Million | - |
| Investments in PPE | -31.04 Million | -17.08 Million | -19.82 Million | -13.17 Million | - |
| Acquisitions | 1.13 Million | - | - | - | - |
| Investment purchases | - | -9 Million | -99.03 Million | -119.33 Million | - |
| Sales/Maturities of investments | 2.53 Million | 213.16 Million | 234 Thousand | 228 Thousand | - |
| Other Investing Activities | -405 Thousand | -1000.00 | - | -1.14 Million | -830 Thousand |
| Financing Cash Flow | -119.32 Million | -35.56 Million | 5.65 Million | -60.43 Million | - |
| Debt repayment | -139.02 Million | -15.78 Million | -24.21 Million | -26.5 Million | - |
| Dividends payments | - | -14.48 Million | -14.48 Million | -28.96 Million | -24.13 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 24 Million | - | - | - | - |
| Other Financing Activities | 24.75 Million | 44 Thousand | 1.37 Million | - | 2.03 Million |
| Accounts receivables | -11.89 Million | - | - | - | - |
| Accounts payables | 12.81 Million | - | - | - | - |
| Inventory | 71.09 Million | -92.75 Million | -39.28 Million | -27.81 Million | - |
| Other working capital | 23.74 Million | - | - | - | - |
| Cash at beginning of period | 310.53 Million | 103.88 Million | 258 Million | 444.6 Million | - |
| Cash at end of period | 368.61 Million | 310.53 Million | 103.88 Million | 258 Million | - |
| Capital Expenditure | -31.04 Million | -17.08 Million | -19.82 Million | -13.17 Million | - |
| Effect of forex changes on cash | -14 Thousand | 12 Thousand | -14 Thousand | 96 Thousand | - |
| Net cash flow / Change in cash | 58.07 Million | 206.65 Million | -154.12 Million | -186.59 Million | - |
| Free Cash Flow | 174.91 Million | 37.97 Million | -60.97 Million | -6.6 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 30.31 Million | 22.21 Million | 43.8 Million | 106.47 Million | 39.77 Million | 13.96 Million |
| Depreciation & Amortization | 9.26 Million | 8.81 Million | 8.79 Million | 34.71 Million | 8.79 Million | 8.68 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 2.11 Million | 2.11 Million | 1.85 Million | 5.4 Million | 1.33 Million | 1.33 Million |
| Change in working capital | -11.22 Million | -33.79 Million | 13.72 Million | 82.93 Million | 6.09 Million | 53.88 Million |
| Other non-cash items | -76 Thousand | -289 Thousand | -96 Thousand | 282 Thousand | -824 Thousand | 441 Thousand |
| Investing Cash Flow | -2.23 Million | -9.53 Million | -8.38 Million | -28.53 Million | -8.26 Million | -13.39 Million |
| Investments in PPE | -2.22 Million | -10.03 Million | -8.38 Million | -31.04 Million | -10.79 Million | -7.05 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | 2.53 Million | 2.53 Million | -6.27 Million |
| Other Investing Activities | -10 Thousand | 500 Thousand | - | -405 Thousand | - | -70 Thousand |
| Financing Cash Flow | -36.54 Million | 28.46 Million | -17.87 Million | -119.32 Million | -50.1 Million | -70.26 Million |
| Debt repayment | -35.2 Million | -29.79 Million | -24.35 Million | -139.02 Million | -48.78 Million | -68.94 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.33 Million | - | 7.8 Million | 24.75 Million | - | -2000.00 |
| Accounts receivables | -5.55 Million | - | - | - | - | - |
| Accounts payables | -13.34 Million | - | - | - | - | - |
| Inventory | 7.6 Million | 12.59 Million | 10.69 Million | 71.09 Million | -5.88 Million | 45.73 Million |
| Other working capital | 879 Thousand | - | - | - | - | - |
| Cash at beginning of period | 385.6 Million | 368.61 Million | 330.72 Million | 310.53 Million | 338.66 Million | 352.9 Million |
| Cash at end of period | 363.06 Million | 385.6 Million | 368.61 Million | 368.61 Million | 330.72 Million | 338.66 Million |
| Capital Expenditure | -2.22 Million | -10.03 Million | -8.38 Million | -31.04 Million | -10.79 Million | -7.05 Million |
| Effect of forex changes on cash | 7000.00 | 12 Thousand | -15 Thousand | -14 Thousand | 22 Thousand | -25 Thousand |
| Net cash flow / Change in cash | -22.53 Million | 16.99 Million | 37.88 Million | 58.07 Million | -7.94 Million | -14.23 Million |
| Free Cash Flow | 14.01 Million | -11.98 Million | 55.77 Million | 174.91 Million | 39.6 Million | 62.39 Million |
3773
AIROLAM
ALOD
0OAL
BHACU
ARML3